Brief: Cumberland Pharmaceuticals Receives Vizient Contract For New Vibativ® 4-Vial Starter Pak
04/08/2025 14:25
Aug 4 (Reuters) - Cumberland Pharmaceuticals Inc CPIX.O: CUMBERLAND PHARMACEUTICALS RECEIVES VIZIENT CONTRACT FOR NEW VIBATIV® 4-VIAL STARTER PAK Source text: ID:nPn64qLFLa Further company coverage: CPIX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cumberland Pharmaceuticals
See all newsBrief: Cumberland Pharmaceuticals Announces Assist-Ssc Trial Top-Line Results
Cumberland Pharmaceuticals Q2 loss widens after Apotex transaction
Brief: Cumberland Pharmaceuticals Announces Special Dividend Of $1.50 Per Share
Cumberland Pharmaceuticals Q1 revenue up 5%; to sell FDA‑approved brands to Apotex for $100 mln
NASDAQ RESUMED AT 09:38 AM